Search research articles
Contact Us
Filters
Showing results (181-190 of 348) with videos related to
Page
of 35
Sort By:
Clinical Cardiology
|
October 16, 2018
Association between ideal cardiovascular health and markers of subclinical cardiovascular disease
Daniel Shpilsky, Claudia Bambs, Kevin Kip, et al.
Diabetes Care
|
January 14, 2015
Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin
Ralph A DeFronzo, Andrew Lewin, Sanjay Patel, et al.
Heart, Lung & Circulation
|
May 1, 2018
Effect of Red Blood Cell Storage Duration on Outcome After Paediatric Cardiac Surgery: A Prospective Observational Study
Arvind Kumar Bishnoi, Pankaj Garg, Kartik Patel, et al.
Diabetes Care
|
January 31, 2015
Initial combination of empagliflozin and linagliptin in subjects with type 2 diabetes
Andrew Lewin, Ralph A DeFronzo, Sanjay Patel, et al.
Innovations (Philadelphia, Pa.)
|
June 10, 2017
Transverse Split Sternotomy: A Mini-Invasive Approach for Repair of Congenital Cardiac Defects
Pankaj Garg, Arvind Kumar Bishnoi, Kartik Patel, et al.
Artificial Organs
|
December 8, 2016
Hemodiafiltration-A Technique for Physiological Correction of Priming Solution in Pediatric Cardiac Surgery: An In Vitro Study
Pankaj Garg, Arvind Kumar Bishnoi, Kartik Patel, et al.
World Journal for Pediatric & Congenital Heart Surgery
|
March 23, 2017
Effect of Prime Blood Storage Duration on Clinical Outcome After Pediatric Cardiac Surgery
Arvind Kumar Bishnoi, Pankaj Garg, Kartik Patel, et al.
Diabetes Care
|
May 23, 2015
Erratum. Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin. Diabetes care 2015;38:384-393
Ralph A DeFronzo, Andrew Lewin, Sanjay Patel, et al.
Diabetes Care
|
May 23, 2015
Erratum. Initial combination of empagliflozin and linagliptin in subjects with type 2 diabetes. Diabetes care 2015;38:394-402
Andrew Lewin, Ralph A DeFronzo, Sanjay Patel, et al.
Diabetes Care
|
October 4, 2012
Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study
Janet B McGill, Lance Sloan, Jennifer Newman, et al.
Page
of 35
Search research articles
Search
Showing results (181-190 of 348) with videos related to
Sort By:
Page
of 35
Clinical Cardiology
|
October 16, 2018
Association between ideal cardiovascular health and markers of subclinical cardiovascular disease
Daniel Shpilsky, Claudia Bambs, Kevin Kip, et al.
Diabetes Care
|
January 14, 2015
Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin
Ralph A DeFronzo, Andrew Lewin, Sanjay Patel, et al.
Heart, Lung & Circulation
|
May 1, 2018
Effect of Red Blood Cell Storage Duration on Outcome After Paediatric Cardiac Surgery: A Prospective Observational Study
Arvind Kumar Bishnoi, Pankaj Garg, Kartik Patel, et al.
Diabetes Care
|
January 31, 2015
Initial combination of empagliflozin and linagliptin in subjects with type 2 diabetes
Andrew Lewin, Ralph A DeFronzo, Sanjay Patel, et al.
Innovations (Philadelphia, Pa.)
|
June 10, 2017
Transverse Split Sternotomy: A Mini-Invasive Approach for Repair of Congenital Cardiac Defects
Pankaj Garg, Arvind Kumar Bishnoi, Kartik Patel, et al.
Artificial Organs
|
December 8, 2016
Hemodiafiltration-A Technique for Physiological Correction of Priming Solution in Pediatric Cardiac Surgery: An In Vitro Study
Pankaj Garg, Arvind Kumar Bishnoi, Kartik Patel, et al.
World Journal for Pediatric & Congenital Heart Surgery
|
March 23, 2017
Effect of Prime Blood Storage Duration on Clinical Outcome After Pediatric Cardiac Surgery
Arvind Kumar Bishnoi, Pankaj Garg, Kartik Patel, et al.
Diabetes Care
|
May 23, 2015
Erratum. Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin. Diabetes care 2015;38:384-393
Ralph A DeFronzo, Andrew Lewin, Sanjay Patel, et al.
Diabetes Care
|
May 23, 2015
Erratum. Initial combination of empagliflozin and linagliptin in subjects with type 2 diabetes. Diabetes care 2015;38:394-402
Andrew Lewin, Ralph A DeFronzo, Sanjay Patel, et al.
Diabetes Care
|
October 4, 2012
Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study
Janet B McGill, Lance Sloan, Jennifer Newman, et al.
Page
of 35